LEADER 00000nam a2200265 a 4500
001 u21027
001 21513
003 SIRSI
005 20060625233800.0
008 030606s1997 xxu00000000000001100eng0d
020 0824793757 (alk. paper)
049 JURF
050 00 RM666.E55|bP476 1997
245 00 Pharmaceutical enzymes /|cedited by Albert Lauwers, Simon
Scharpé.
260 New York :|bMarcel Dekker,|c1997
300 viii, 401 p. :|bill. ;|c24 cm.
440 0 Drugs and the pharmaceutical sciences ;|v84
504 Includes bibliographical references and index.
505 0 Pt.1. Bioavailability of pharmaceutical enzymes --
Biopharmaceuticl aspects of enzyme absorption -- The
endothelium monolayer: barrier to enzyme and drug delivery
-- Pt.2. Tailoring of pharmaceutical enzymes -- Enzyme-
albumin conjugates: advantages and problems with targeting
-- Acyl enzymes as prodrugs -- Molecular modeling of
pharmaceutically important targets -- Pt.3. Biochemical
and pharmacological properties -- The cysteine proteinases
from the latex of Carica papaya L -- Bromelain --
Hyaluronidase -- Pancreatic enzyme replacement -- I-
asparaginase: an essential antineoplastic drug --
Macrophage-targeted glucocerebrosidase: a therapeutically
effective enzyme replacement product for Gaucher Disease -
- Deoxyribonuclease I -- Therapeutic protein inhibitors of
elastase -- Pt.4. Standardization and methodology -- Good
standardization practices -- Assays.
650 0 Enzymes|xTherapeutic use
650 0 Enzymes|xTesting
700 1 Lauwers, Albert
700 1 Scharpé, Simon|d1944-
Female Library
|
RM666.E55 P476 1997 |
Available |
Female Library
|
RM666.E55 P476 1997 c.2 |
Available |
|